Mesenchymal Stem Cells for Age-Related Frailty
NCT05284604
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
WITHDRAWN
Status
FED
Sponsor class
Stopped
Insufficient funding
Conditions
Frailty
Interventions
DRUG:
Mesenchymal Stem Cells (MSCs)
Sponsor
VA Office of Research and Development
Collaborators
[object Object]
[object Object]